By contrast, Gorlin’s syndrome patients have a low base level of spontaneous LY6D+ cells, respond well to SMOi, but induce residual LY6D+ persister tumors that recur upon SMOi cessation21. Here, LY6D is linked to nevoid basal cell carcinoma syndrome.